[Obesity, inflammation and insulin resistance: role of gp 130 receptor ligands].
暂无分享,去创建一个
[1] J. Kastelein,et al. Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease , 2007, Diabetes, obesity & metabolism.
[2] M. Febbraio. gp130 receptor ligands as potential therapeutic targets for obesity. , 2007, The Journal of clinical investigation.
[3] J. Prieto,et al. Cardiotrophin‐1 is an essential factor in the natural defense of the liver against apoptosis , 2007, Hepatology.
[4] J. Prieto,et al. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning , 2006, The Journal of experimental medicine.
[5] A. Miyajima,et al. Oncostatin M Inhibits Adipogenesis through the RAS/ERK and STAT5 Signaling Pathways* , 2006, Journal of Biological Chemistry.
[6] M. Febbraio,et al. Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. , 2006, Endocrinology.
[7] B. Viollet,et al. Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders , 2006, The Journal of physiology.
[8] R. Ahima. Overcoming insulin resistance with CNTF , 2006, Nature Medicine.
[9] M. Febbraio,et al. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK , 2006, Nature Medicine.
[10] S. Movérare-Skrtic,et al. Leukemia inhibitory factor reduces body fat mass in ovariectomized mice. , 2006, European journal of endocrinology.
[11] T. Mandrup-Poulsen,et al. Interleukin-6 and diabetes: the good, the bad, or the indifferent? , 2005, Diabetes.
[12] J. Flier,et al. Neurogenesis in the Hypothalamus of Adult Mice: Potential Role in Energy Balance , 2005, Science.
[13] M. D. Parra,et al. Implicación de la IL-6 y su polimorfismo -174G>C en el control del peso corporal y en las complicaciones metabólicas asociadas a la obesidad , 2005 .
[14] A. Martí,et al. Does weight loss prognosis depend on genetic make‐up? , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[15] P. Kern,et al. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. , 2004, American journal of physiology. Endocrinology and metabolism.
[16] J. Flier. Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.
[17] G. Yancopoulos,et al. Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] T. Zimmers,et al. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. , 2003, Diabetes.
[19] S. Rose-John,et al. Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited , 2003, The Journal of Biological Chemistry.
[20] U. Das. Is obesity an inflammatory condition? , 2001, Nutrition.
[21] W. Wood,et al. Cardiotrophin-1 , 1995, The Journal of Biological Chemistry.
[22] G. J. Kirkpatrick. The good, the bad, the indifferent , 1988 .
[23] M. Fortuño,et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. , 2008, American journal of physiology. Endocrinology and metabolism.
[24] A. Aljada,et al. Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.
[25] C. Ohlsson,et al. Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.